| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |